Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Johnson and Johnson
Federal Trade Commission
Dow
AstraZeneca
Accenture
Cantor Fitzgerald
McKinsey
Chinese Patent Office

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,908,850

« Back to Dashboard

Summary for Patent: 5,908,850
Title: Method of treating attention deficit disorders with d-threo methylphenidate
Abstract:Methods for treating Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, AIDS Dementia Complex and cognitive decline in HIV-AIDS while minimizing drug hypersensitivity, toxicity, side effects, euphoric effect, and drug abuse potential by administration of d-threo-methylphenidate or pharmaceutically acceptable salts thereof.
Inventor(s): Zeitlin; Andrew L. (Millington, NJ), Dariani; Maghsoud M. (Fanwood, NJ), Stirling; David I. (Branchburg, NJ)
Assignee: Celgene Corporation (Warren, NJ)
Application Number:08/827,230
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,908,850
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 5,908,850

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 5,908,850

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 306266 ➤ Try a Free Trial
Austria 368458 ➤ Try a Free Trial
Australia 2002318302 ➤ Try a Free Trial
Australia 738521 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Cerilliant
UBS
Fuji
US Army
Cipla
Teva
Chinese Patent Office
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.